SCHEMBL6662860

SCHEMBL6662860

N#Cc1ccc(Nc2ncnc3ccccc23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 1.00
EGFR P00533 8/20 0.69
ERBB2 P04626 2/20 0.69
AURKB Q96GD4 2/20 0.69
CLK4 Q9HAZ1 2/20 0.69
DAPK3 O43293 1/20 0.69
MAP4K4 O95819 1/20 0.69
ABL1 P00519 1/20 0.69
PIM1 P11309 1/20 0.69
PRKACA P17612 1/20 0.69
LTK P29376 1/20 0.69
MAPK8 P45983 1/20 0.69
CSNK1A1 P48729 1/20 0.69
RPS6KA3 P51812 1/20 0.69
LIMK1 P53667 1/20 0.69
MAP2K1 Q02750 1/20 0.69
ACVR1 Q04771 1/20 0.69
TYRO3 Q06418 1/20 0.69
MAP4K2 Q12851 1/20 0.69
ROCK1 Q13464 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8810621 0.84 ABCG2 (0.72) ABCG2EGFRERBB2AURKBCLK4
Hydrochloric Acid SCHEMBL9017046 0.83 ABCG2 (0.97) ABCG2EGFRERBB2AURKBCLK4
SCHEMBL6684273 0.82 ABCG2 (0.67) ABCG2EGFRERBB2AURKBCLK4
SCHEMBL8920 0.82 EGFR (1.00) ABCG2EGFRERBB2AURKBCLK4
SCHEMBL29941271 0.82 EGFR (1.00) ABCG2EGFRERBB2AURKBCLK4
SCHEMBL6684283 0.81 ABCG2 (0.66) ABCG2EGFRERBB2AURKBCLK4
SCHEMBL6686019 0.81 ABCG2 (0.66) ABCG2EGFRERBB2AURKBCLK4
Hydrochloric Acid SCHEMBL8808235 0.81 EGFR (0.90) ABCG2EGFRERBB2AURKBCLK4
Hydrochloric Acid SCHEMBL20856873 0.80 EGFR (0.96) ABCG2EGFRERBB2AURKBCLK4
Hydrochloric Acid SCHEMBL29394578 0.80 EGFR (0.96) ABCG2EGFRERBB2AURKBCLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO disclosed